Page 132 - 南京医科大学学报自然科学版
P. 132

第41卷第11期
               ·1694 ·                           南 京    医 科 大 学 学         报                        2021年11月


                   24(2):198-204                                     packaged Cas9 mRNA and a VEGFA ⁃ targeting guide
             [53] KUMAR M,KELLER B,MAKALOU N,et al. Systematic       RNA prevents wet age ⁃ related macular degeneration in
                   determination of the packaging limit of lentiviral vectors  mice[J]. Nat Biomed Eng,2021,5(2):144-156
                  [J]. Hum Gene Ther,2001,12(15):1893-1905      [57] LI L,HU S,CHEN X. Non ⁃ viral delivery systems for
             [54] JOGLEKAR A V,SANDOVAL S. Pseudotyped lentiviral    CRISPR/Cas9 ⁃ based genome editing :challenges and
                   vectors:one vector,many guises[J]. Hum Gene Ther  opportunities[J]. Biomaterials,2018,171:207-218
                   Methods,2017,28(6):291-301                   [58] ALTON E W F W,ARMSTRONG D K,ASHBY D,et al.
             [55] ORTINSKI P I,O’DONOVAN B,DONG X,et al. Inte⁃       Repeated nebulisation of non⁃viral CFTR gene therapy in
                   grase⁃deficient lentiviral vector as an all⁃in⁃one platform  patients with cystic fibrosis:a randomised,double⁃blind,
                   for highly efficient CRISPR/Cas9 ⁃ mediated gene editing  placebo ⁃ controlled,phase 2b trial[J]. Lancet Respir
                  [J]. Mol Ther Methods Clin Dev,2017,5:153-164      Med,2015,3(9):684-691
             [56] LING S,YANG S,HU X,et al. Lentiviral delivery of co⁃                    [收稿日期] 2021-03-31




              




             (上接第1637页)                                         [20] LIM P S,CHEN H P,CHEN C H,et al. Association be⁃
                   jury,increased solute transport,or progression to encapsu⁃  tween redox status of serum albumin and peritoneal mem⁃
                   lating peritoneal sclerosis during peritoneal dialysis:a  brane transport properties in patients on peritoneal dialy⁃
                   multicentre study in Japan[J]. Nephrol Dial Transplant,  sis[J]. Blood Purif,2015,40(3):243-249
                   2007,22(2):560-567                           [21] ASANO M,ISHII T,HIRAYAMA A,et al. Differences in
             [18] KANG D H,YOON K I,CHOI K B,et al. Relationship of  peritoneal solute transport rates in peritoneal dialysis[J].
                   peritoneal membrane transport characteristics to the nutri⁃  Clin Exp Nephrol,2019,23(1):122-134
                   tional status in CAPD patients[J]. Nephrol Dial Trans⁃  [22] BERNARDO A P,CONTESSE S A,BAJO M A,et al.
                   plant,1999,14(7):1715-1722                        Peritoneal membrane phosphate transport status:a corner⁃
             [19] LIU Y,HUANG R,GUO Q,et al. Baseline higher perito⁃  stone in phosphate handling in peritoneal dialysis[J].
                   neal transport had been associated with worse nutritional  Clin J Am Soc Nephrol,2011,6(3):591-597
                   status of incident continuous ambulatory peritoneal dialy⁃  [23] NEURATH M F. IL⁃36 in chronic inflammation and can⁃
                   sis patients in Southern China:a 1⁃year prospective study  cer[J]. Cytokine Growth Factor Rev,2020,55:70-79
                  [J]. Br J Nutr,2015,114(3):398-405                                      [收稿日期] 2021-03-06
   127   128   129   130   131   132   133   134   135   136   137